Concorde Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-59,186
| Closed | -$3.22M | – | 131 |
|
|
2022
Q1 | $3.22M | Buy |
59,186
+36,232
| +158% | +$1.97M | 2.14% | 6 |
|
|
2021
Q4 | $1.27M | Buy |
22,954
+2,476
| +12% | +$136K | 0.75% | 44 |
|
|
2021
Q3 | $978K | Sell |
20,478
-43,334
| -68% | -$2.07M | 0.56% | 57 |
|
|
2021
Q2 | $3.18M | Buy |
63,812
+27,570
| +76% | +$1.37M | 1.78% | 7 |
|
|
2021
Q1 | $1.62M | Buy |
+36,242
| New | +$1.62M | 0.93% | 31 |
|